The effects of sequential therapy using anti-resorptive agents after administering once-weekly teriparatide or twice-weekly teriparatide [0.03%]
使用特立帕肽单周剂或双周剂后序贯抗吸收药物治疗的效果
Hidehiro Matsumoto,Manabu Tsukamoto,Nobukazu Okimoto et al.
Hidehiro Matsumoto et al.
Introduction: Studies launched in Japan on once-weekly teriparatide (1/W-TPTD) and twice-weekly teriparatide (2/W-TPTD) are limited. Therefore, we examined the effects of sequential therapy using anti-resorptive agents af...
Shoichiro Tani
Shoichiro Tani
Skeletal stem cells (SSCs) underlie skeletal development, homeostasis, regeneration, and aging, yet their identities and functions are highly heterogeneous across anatomical sites and life stages. Mouse genetic studies have identified multi...
Comment on: "Trolox, r-irisin and resveratrol cocktail to counteract osteoblast metabolism alterations in osteoarthritis and osteoporosis"-proposal to validate cocktail efficacy in female osteoblasts [0.03%]
关于“白藜芦醇、r-irisin和trolox鸡尾酒以对抗骨关节炎和骨质疏松症中成骨细胞代谢的改变”的评论-建议在女性成骨细胞中验证鸡尾酒的有效性
Jianying Chen,Xianda Zheng,Rongrong Chen
Jianying Chen
Identifying the clinical indicator for surgical intervention in medication-related osteonecrosis of the jaw [0.03%]
与颌骨药物相关性坏死的手术干预临床指征的研究
Yoshiaki Tadokoro,Takumi Hasegawa,Daisuke Takeda et al.
Yoshiaki Tadokoro et al.
Introduction: Surgery has increasingly been reported as an effective treatment for medication-related osteonecrosis of the jaw (MRONJ), but concrete intervention criteria are lacking. On computed tomography (CT) images, t...
Response to the letter regarding "Postoperative risks of type 2 diabetes in elderly hip fracture patients: a propensity score-matched study" [0.03%]
关于“老年髋部骨折患者2型糖尿病术后风险:倾向性评分匹配研究”的回信
Yu Mori,Kunio Tarasawa,Hidetatsu Tanaka et al.
Yu Mori et al.
Response to the letter regarding "One-year bone mineral density gains with anti-osteoporotic medications and clinical factors associated with non-BMD gainers" [0.03%]
关于“抗骨质疏松药物一年的骨密度获益及非骨密度获益者的临床特征”的回信
Seol A Jang,Seok-Jae Heo,Su Jin Kwon et al.
Seol A Jang et al.
Association between femoral localized cortical thickening ("beaking" or "flaring") and bisphosphonate duration in glucocorticoid-induced osteoporosis [0.03%]
糖皮质激素所致骨质疏松患者股骨局部皮质增厚（“鸟嘴”或“喇叭形”）与双膦酸盐使用时间的相关性研究
Yudai Yano,Sachiko Kawasaki,Takaaki Kosugi et al.
Yudai Yano et al.
Introduction: Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis, and bisphosphonates (BPs) are widely used for treatment. Localized cortical thickening (LCT, "beaking" or "flarin...